Trade Summary

3 months ago, Wilson Troy Edward, serving as Pres, CEO at Kura Oncology, Inc. (KURA), purchased 50,000 shares at $8.20 per share, for a total transaction value of $410,145.00. Following this transaction, Wilson Troy Edward now holds 680,162 shares of KURA.

This purchase represents a 8.00% increase in Wilson Troy Edward's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, September 8, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 9, 2025, 1 day after the trade was made.

Kura Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.